Maxim Group upgraded IntelliPharmaCeutics International (NASDAQ: IPCI) from Hold to Buy with a price target of $7.00 (from $3.00).Analyst Jason ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE